ReviewTranslational oncology2023

A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?

Zeinab Davoodi-Moghaddam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.